Dalian, China

Dalian Chromas Bioscience Co., Ltd.

USPTO Granted Patents = 5

% Expired Patents = 20.0


Forward Citations = 4

Loading Chart...
Loading Chart...

15 inventors (with patents filed for the assignee):

goldMedal Xiaojun Peng (5 out of 15 patents)

silverMedal Jiangli Fan (5 out of 13 patents)

bronzeMedal Jingyun Wang (4 out of 8 patents)

4.  Shiguo Sun (3 out of 10 patents)

5.  Hua Zhang (1 out of 4 patents)

6.  Honglin Li (1 out of 1 patent)

7.  Zhigang Yang (1 out of 2 patents)

8.  Yanxia He (1 out of 2 patents)

9.  Fengling Song (1 out of 3 patents)

10.  Jianjun Du (1 out of 2 patents)

11.  Jianzhou Zhang (1 out of 3 patents)

12.  Mingle Li (1 out of 2 patents)

13.  Qichao Yao (1 out of 2 patents)

14.  Haidong Li (1 out of 1 patent)

15.  Yana Bian (1 out of 1 patent)


5 patents:

Company Overview
Dalian Chromas Bioscience Co., Ltd. is a leading biotechnology company specializing in research and development of innovative solutions for the healthcare industry. With a focus on precision medicine, our team of scientists and experts work tirelessly to discover and develop cutting-edge products that improve patient outcomes. Our commitment to excellence and dedication to advancing healthcare make us a trusted partner for pharmaceutical companies, research institutions, and healthcare providers worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#6 in Dalian

#5,271 in China

Dalian, CN
Dalian, China
Forward Citations = 4

15 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dalian Chromas Bioscience Co., Ltd.. Retrieved from https://idiyas.com/company/dalian-chromas-bioscience-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…